IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation

TY - CONF

T1 - IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation

AU - Ozair, Ahmad

AU - Ahluwalia, Manmeet

N1 - Bhanja, D., Wilding, H., Moeckel, C., Hong, J., Baroz, A., Stahl, C., Ozair, A., Dao, J., Sivik, J., Drabick, J., Pameijer, C., Ahluwalia, M., & Mansouri, A. (2023). IMMU-02. Is Dual Agent Immunotherapy Shifting the Epidemiology of Melanoma Brain Metastases? A Real-World Analysis and Single-Institution Validation. Neuro-Oncology, 25(Supplement_5), v141-v141. https://doi.org/10.1093/neuonc/noad179.0534

PY - 2023/11/15

Y1 - 2023/11/15

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/5072

M3 - Presentation

T2 - Neuro-Oncology

Y2 - 15 November 2023

ER -